Task area b-10 is to evaluate monovalent vaccines for immunogenicity and efficacy against veev and eeev aerosol challenge in cynomolgus macaques.
Ended Awarded Last action
- Contract number
- 75N93020F00002
- Awardee
-
The Administrators Of Tulane Educational Fund UEI XNY5ULPU8EN6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,371,373
Award facts
- Contract value 100% obligated
- $1,371,372.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- New Orleans, LA 70118, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $87,880 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,283,493 |
About this award
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.37 million delivery order contract to Tulane University under the agency's Preclinical Models of Infectious Diseases 2017-2024 master IDIQ. Tulane will evaluate monovalent vaccines for immunogenicity and efficacy against Venezuelan equine encephalitis and eastern equine encephalitis aerosol challenge in cynomolgus macaques, as outlined under Task Area B-10 of the IDIQ. The two-year period of performance for this task order begins in September 2020. As the prime contractor, Tulane will conduct the preclinical vaccine studies at its facilities in New Orleans, Louisiana. No subcontractors or set aside designations were indicated. The award provides funding for Tulane to evaluate potential vaccines in nonhuman primate models, in support of NIAID's infectious disease research mission.
Quick answers
Who was awarded contract 75N93020F00002?
75N93020F00002 was awarded to The Administrators Of Tulane Educational Fund by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 21, 2020.
How much is contract 75N93020F00002 worth?
The government has obligated $1,371,373 on 75N93020F00002.
Is contract 75N93020F00002 an order under another contract?
Yes. 75N93020F00002 is a delivery order under HHSN272201700033I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93020F00002 competed?
The extent of competition for 75N93020F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award